Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics

NCT02288676 is registered in ClinicalTrials.gov with McGill University as lead sponsor.

NCT NCT02288676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02288676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
Lead sponsor
McGill University
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2014
Completion date
October 31, 2026
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early diagnosis, endometrial cancer, endometrial neoplasms, ovarian cancer, ovarian neoplasms, reduced morbidity, reduced mortality, safety, screening